SF3A1 and pancreatic cancer: new evidence for the association of the spliceosome and cancer

A two-stage case-control study was conducted to examine the association between six candidate U2-depedent spliceosome genes (SRSF1, SRSF2, SF3A1, SF3B1, SF1 and PRPF40B) and pancreatic cancer (PC). Subjects with one or two T alleles at rs2074733 in SF3A1 had a lower risk of PC compared to those with two C alleles in combined two populations (OR: 0.59, 95% confidence interval: 0.48–0.73, False discovery rate (FDR)-P = 1.5E-05). Moreover, the presence of the higher-risk genotype at rs2074733 plus smoking or drinking had synergic effects on PC risk. These findings illustrate that RNA splicing-related genes appear to be associated with the occurrence of PC, and show synergic interactions with smoking and drinking in the additive model. In the future, our novel findings should be further confirmed by functional studies and independent large-scale population studies.

[1]  X. Miao,et al.  Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population , 2015, Molecular carcinogenesis.

[2]  X. Miao,et al.  [Association between pancreatic cancer risk and the interaction of U2AF65 gene polymorphisms and smoking]. , 2014, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[3]  K. Masuda,et al.  Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells , 2014, Oncogene.

[4]  Paul Wordsworth,et al.  Novel Rheumatoid Arthritis Susceptibility Locus at 22q12 Identified in an Extended UK Genome-Wide Association Study , 2013, Arthritis & rheumatology.

[5]  E. Lander,et al.  Lessons from the Cancer Genome , 2013, Cell.

[6]  A. Bowcock,et al.  Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma , 2013, Nature Genetics.

[7]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[8]  Lincoln D. Stein,et al.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.

[9]  Angela N. Brooks,et al.  Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.

[10]  Joshua F. McMichael,et al.  Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition , 2012, Nature.

[11]  R. Padgett.  New connections between splicing and human disease. , 2012, Trends in genetics : TIG.

[12]  E. Giné,et al.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia , 2011, Nature Genetics.

[13]  Wen Tan,et al.  Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations , 2011, Nature Genetics.

[14]  A. Sivachenko,et al.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. , 2011, The New England journal of medicine.

[15]  S. Sugano,et al.  Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.

[16]  Wen Tan,et al.  A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese , 2011, Nature Genetics.

[17]  C. Deng,et al.  SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance , 2010, International journal of biological sciences.

[18]  S. Ishiura,et al.  Alcoholism and Alternative Splicing of Candidate Genes , 2010, International journal of environmental research and public health.

[19]  Wei Zheng,et al.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.

[20]  Geoffrey S. Tobias,et al.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.

[21]  Jack A. Taylor,et al.  SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies , 2009, Nucleic Acids Res..

[22]  Alison P. Klein,et al.  Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene , 2009, Science.

[23]  M. Carmo-Fonseca,et al.  The emerging role of splicing factors in cancer , 2008, EMBO reports.

[24]  K. Scotto,et al.  Caffeine Regulates Alternative Splicing in a Subset of Cancer-Associated Genes: a Role for SC35 , 2007, Molecular and Cellular Biology.

[25]  A. Krainer,et al.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene , 2007, Nature Structural &Molecular Biology.

[26]  Lars Alfredsson,et al.  Calculating measures of biological interaction using R , 2006, European Journal of Epidemiology.

[27]  Michael R Green,et al.  Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. , 2005, Molecular cell.

[28]  J. Ko,et al.  Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines , 2005, Environmental and molecular mutagenesis.

[29]  F. Clark,et al.  Understanding alternative splicing: towards a cellular code , 2005, Nature Reviews Molecular Cell Biology.

[30]  A. Krämer,et al.  Human splicing factor SF3a, but not SF1, is essential for pre-mRNA splicing in vivo. , 2005, Molecular biology of the cell.

[31]  P. Parsons,et al.  Novel markers for poor prognosis in head and neck cancer , 2005, International journal of cancer.

[32]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[33]  Stephen N. Jones,et al.  An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis* , 2004, Journal of Biological Chemistry.

[34]  M. Pacyna‐Gengelbach,et al.  Gene expression profiles in human non-small and small-cell lung cancers. , 2003, European journal of cancer.

[35]  Gonghuan Yang,et al.  Pancreatic cancer mortality in China (1991-2000). , 2003, World journal of gastroenterology.

[36]  A. Ziegler,et al.  BRCA2 germline mutations in familial pancreatic carcinoma. , 2003, Journal of the National Cancer Institute.

[37]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[38]  M Blettner,et al.  Traditional reviews, meta-analyses and pooled analyses in epidemiology. , 1999, International journal of epidemiology.

[39]  M. Korc,et al.  Increased mdm2 expression and immunoreactivity in human pancreatic ductal adenocarcinoma. , 1994, International journal of oncology.

[40]  F. Hamdy,et al.  THE NEW ENGLAND JOURNAL OF MEDICINE , 1977, The Lancet.

[41]  X. Miao,et al.  Non-linear dose-response relationship between cigarette smoking and pancreatic cancer risk: evidence from a meta-analysis of 42 observational studies. , 2014, European journal of cancer.

[42]  E. Diamandis,et al.  Pancreatic cancer. , 2013, Clinical chemistry.

[43]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[44]  Anne-Laure Boulesteix,et al.  Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[45]  Huili,et al.  Pancreatic cancer mortality in China （1991-2000） , 2003 .

[46]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[47]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[48]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.